The 20th Annual AVCJ China Forum
Event summary
The pioneer China-focused international private equity and venture capital event, the AVCJ China Forum, has remained unrivalled as the most influential gathering of domestic Chinese and international institutional investors, fund managers and professional advisors since its inception in 2001.
From an intimate gathering of like-minded professionals to the much-anticipated event it is today, the AVCJ China Forum has grown with the local market to welcome more than 520 delegates including 245 institutional investors who are keen on the China-related opportunities.
This year, the forum will celebrate 20 years in the market with a thorough program that combines editorially-driven topics, high-level speakers, deep industry knowledge and superb organization into a highly anticipated event that predicts trends, create strategies and forges lasting partnerships in China and beyond.
Check out Cooley Expo or visit the event website for detailed agenda and speaker list.
For more information, please email Sandra Sun.
Featured agenda items
Wednesday, October 13, 2021: 4:15 - 5:00 pm
Technology: Where are China’s unicorns?
China’s technology sector is growing increasingly polarised. At one end of the spectrum, established unicorns continue to raise capital at elevated valuations from an array of investors. At the other, once-star start-ups that are falling out of favour, with much talk of down rounds and dirty term sheets. Post-COVID-19, investors are being more selective about cash-burning B2C players and placing greater emphasis on B2B. Our expert panellists identify the future category killers in China’s digital economy.
- Which segments are most likely to see down rounds?
- How is investor appetite changing for late-stage rounds?
- Will enterprise services evolve into a sustainable industry?
- What do tighter regulations mean for unicorns and IPO listing?
Cooley partner Xun Zeng is a featured speaker.
Thursday, October 14, 2021: 9:30 – 10:30 am
LP expectations: Capturing growth and returns in China
Even as growth moderates and external challenges arise, China remains the most significant exposure in many LPs’ Asian portfolios. Nevertheless, as the PRC private market evolves and matures, LPs’ expectations of fund managers and their investments are changing. In this session, a group of senior and influential LPs will discuss their thoughts and strategies for approaching the market, as well as debate the risks and rewards.
- Have the US election and the changing macro climate altered LPs’ strategies towards China?
- Top-tier or “dark horse” funds? Venture capital, growth, or buyout? Niche vs generalists?
- What are LPs expecting from GPs, now that ESG criteria have become a significant factor in manager selection?
- Are there any new tools or strategies to identify and build trust with new managers as travel restrictions continue?
Cooley partner Jingyi Xu is a featured speaker.
Thursday, October 14, 2021: 12:00 – 1:00 pm
Capital market reforms and the future of exits in China
Ongoing capital markets reform has revived interest in IPO exits in China. In the first 10 months of 2020, the number of IPO exits in local bourses accounted for almost 80% of all markets. The approval of the first foreign VIE-structured company listed on the STAR board is expected to boost its competitiveness as an exit venue. With unforeseen regulatory challenges to domestic listings, trade-sales and secondaries have dominated exits in recent years. Can IPOs recapture exit kudos? Our experts assess the outlook.
- What were the most fruitful exit routes in 2020?
- Have secondary solutions evolved to meet liquidity needs in China?
- Will China and Hong Kong overcome the US as the preferred listing destinations for Chinese companies?
- What can China do to outperform as a listing and trading venue, and what lessons can be learned from international role models?
Cooley partner Ethan Jin is a featured speaker.
This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.